<DOC>
	<DOCNO>NCT01227083</DOCNO>
	<brief_summary>Comparison responsiveness two different asthma-specific QOL measure ( AQLQ cAQOL ) Korean patient persistent asthma</brief_summary>
	<brief_title>2nd_Computerized Asthma Specific Quality Life ( cAQOL )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Patient age 2070 year Patient diagnose asthma six month ago Asthma diagnosis Airway reversibility , FEV1 ≥ 12 % 200mL Airway hyperresponsiveness , PC20 &lt; 16 mg/mL More two week , 2 time day excess 20 % PEFR diurnal variability patient FEV1 55100 % predict value patient Inhaled corticosteroid alone inhaled corticosteroid beta agonist use patient Currently , least one asthma symptom , asthma control test ( ACT • Asthma Control Test ) score le 19 character Patients sufficiently listen purpose content trial property investigational product voluntarily agree participation sign write consent approve IRB Ajou University Medical Center participation trial Current smoking smoking past 15packyears Patients show symptom acute disease within 14 day begin trial ( administration trial medication ) Recent change asthma treatment 28days Chronic disease affect quality life</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>AQLQ cAQOL</keyword>
</DOC>